Annual CFO
-$300.87M$181.81M-152.70%
Summary
- Current Value
- As of today, RNA annual cash from operations is -$300.87M, down -152.70% on
- Historical Performance
- RNA annual cash from operations is down -217.33% over the past 3 years, and down -12183.13% over the past 5 years
- All-Time High Comparison
- RNA annual cash from operations is currently -12183.13% below its historical high of $2.49M set on
- 3-Year Low Comparison
- RNA annual cash from operations is at its 3-year low
- Sector Comparison
- RNA annual cash from operations is higher than 2.20% of companies in Healthcare sector
Cash From Operations Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Operations | -$300.87M | -152.7% | -217.3% | -10000.0% | -3016.2% | |
| Quarterly Cash From Operations | -$156.17M | -138.0% | -388.7% | -1613.7% | -7386.7% | |
| TTM Cash From Operations | -$580.54M | -214.7% | -371.1% | -1897.5% | -10000.0% | |
| Price | $72.37 | +135.0% | +264.9% | +185.8% | – | |
| Annual Cash From Investing | -$854.20M | -556.7% | -935.2% | -10000.0% | -10000.0% | |
| Annual Cash From Financing | $1.19B | +1170.3% | +576.3% | +1236.2% | +10000.0% | |
| Annual Free Cash Flow | -$307.94M | -149.8% | -212.5% | -10000.0% | -3073.3% | |
| Annual CAPEX | $7.07M | +67.1% | +88.9% | +2906.8% | +10000.0% | |
| Annual Net Income | -$322.30M | -51.9% | -173.1% | -1203.1% | -2773.6% |
Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$119.06M | -152.7% | |
| 5Y | -$37.12M | N/A | -710.6% |
| All | $2.49M | >-9999.0% |
Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$300.87M | at low | |
| 5Y | -$300.87M | at low | |
| All | -$300.87M | at low |
Cash From Operations History
| Year | Value | Change |
|---|---|---|
| -$300.87M | -152.7% | |
| -$119.06M | +12.6% | |
| -$136.27M | -43.7% | |
| -$94.81M | -155.4% |
| Year | Value | Change |
|---|---|---|
| -$37.12M | -1,590.6% | |
| $2.49M | +125.8% | |
| -$9.66M | - |
FAQ
What is the current annual cash from operations of RNA?
As of today, RNA annual cash from operations is -$300.87M
What is 1-year change in RNA annual cash from operations?
RNA annual cash from operations is down -152.70% year-over-year
What is 3-year change in RNA annual cash from operations?
RNA annual cash from operations is down -217.33% over the past 3 years
How far is RNA annual cash from operations from its all-time high?
RNA annual cash from operations is currently -12183.13% below its historical high of $2.49M set on December 31, 2019
How does RNA annual cash from operations rank versus sector peers?
RNA annual cash from operations is higher than 2.20% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly CFO
-$156.17M$43.49M+21.78%
Summary
- Current Value
- As of today, RNA quarterly cash from operations is -$156.17M, up +21.78% on
- Historical Performance
- RNA quarterly cash from operations is down -138.01% year-over-year, and down -388.67% over the past 3 years
- All-Time High Comparison
- RNA quarterly cash from operations is currently -1046.45% below its historical high of $16.50M set on
- 3-Year Low Comparison
- RNA quarterly cash from operations is +21.78% above its 3-year low of -$199.67M reached on
- Sector Comparison
- RNA quarterly cash from operations is higher than 0.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Operations | -$156.17M | +21.8% | -138.0% | -388.7% | -1613.7% | |
| Annual Cash From Operations | -$300.87M | – | -152.7% | -217.3% | -10000.0% | |
| TTM Cash From Operations | -$580.54M | -18.5% | -214.7% | -371.1% | -1897.5% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| Quarterly Cash From Investing | -$587.93M | -417.0% | -21.9% | -5478.0% | -10000.0% | |
| Quarterly Cash From Financing | $850.37M | +10000.0% | +148.3% | +2046.3% | +10000.0% | |
| Quarterly Free Cash Flow | -$156.89M | +22.7% | -133.1% | -392.5% | -1475.5% | |
| Quarterly CAPEX | $712.00K | -78.7% | -58.2% | +565.4% | -15.7% | |
| Quarterly Net Income | -$174.44M | -10.9% | -117.0% | -300.1% | -1425.0% |
Quarterly Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$99.87M | N/A | -56.4% |
| 3Y | $16.50M | -1046.5% | |
| 5Y | $16.50M | -1046.5% | |
| All | $16.50M | -1046.5% |
Quarterly Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$199.67M | +21.8% | |
| 3Y | -$199.67M | +21.8% | |
| 5Y | -$199.67M | +21.8% | |
| All | -$199.67M | +21.8% |
Quarterly Cash From Operations History
FAQ
What is the current quarterly cash from operations of RNA?
As of today, RNA quarterly cash from operations is -$156.17M
What is RNA quarterly cash from operations most recent change?
RNA quarterly cash from operations was up +21.78% on September 30, 2025
What is 1-year change in RNA quarterly cash from operations?
RNA quarterly cash from operations is down -138.01% year-over-year
How far is RNA quarterly cash from operations from its all-time high?
RNA quarterly cash from operations is currently -1046.45% below its historical high of $16.50M set on December 31, 2023
How does RNA quarterly cash from operations rank versus sector peers?
RNA quarterly cash from operations is higher than 0.73% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM CFO
-$580.54M$90.56M-18.48%
Summary
- Current Value
- As of today, RNA TTM cash from operations is -$580.54M, down -18.48% on
- Historical Performance
- RNA TTM cash from operations is down -214.66% year-over-year, and down -371.14% over the past 3 years
- All-Time High Comparison
- RNA TTM cash from operations is currently -4434.32% below its historical high of $13.39M set on
- 3-Year Low Comparison
- RNA TTM cash from operations is at its 3-year low
- Sector Comparison
- RNA TTM cash from operations is higher than 0.64% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Operations | -$580.54M | -18.5% | -214.7% | -371.1% | -1897.5% | |
| Annual Cash From Operations | -$300.87M | – | -152.7% | -217.3% | -10000.0% | |
| Quarterly Cash From Operations | -$156.17M | +21.8% | -138.0% | -388.7% | -1613.7% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| TTM Cash From Investing | -$309.43M | -51.7% | +58.1% | -16.2% | -10000.0% | |
| TTM Cash From Financing | $869.80M | +140.3% | -28.1% | +606.3% | +153.3% | |
| TTM Free Cash Flow | -$592.26M | -17.8% | -214.2% | -366.7% | -1873.6% | |
| TTM CAPEX | $11.72M | -7.8% | +192.2% | +201.1% | +1139.3% | |
| TTM Net Income | -$549.79M | -20.6% | -96.0% | -239.2% | -1328.7% |
TTM Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$300.87M | N/A | -93.0% |
| 3Y | -$119.06M | -387.6% | |
| 5Y | -$37.12M | N/A | -1464.1% |
| All | $13.39M | -4434.3% |
TTM Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$580.54M | at low | |
| 3Y | -$580.54M | at low | |
| 5Y | -$580.54M | at low | |
| All | -$580.54M | at low |
TTM Cash From Operations History
FAQ
What is the current TTM cash from operations of RNA?
As of today, RNA TTM cash from operations is -$580.54M
What is RNA TTM cash from operations most recent change?
RNA TTM cash from operations was down -18.48% on September 30, 2025
What is 1-year change in RNA TTM cash from operations?
RNA TTM cash from operations is down -214.66% year-over-year
How far is RNA TTM cash from operations from its all-time high?
RNA TTM cash from operations is currently -4434.32% below its historical high of $13.39M set on June 30, 2019
How does RNA TTM cash from operations rank versus sector peers?
RNA TTM cash from operations is higher than 0.64% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna